期刊文献+

NKG2A、NKG2D在食管鳞癌不同病理分期的表达及其相关性分析 被引量:1

Expression of NKG2A and NKG2D in different stage of esophageal squamous cell carcinoma and its correlation
原文传递
导出
摘要 目的分析不同病理分期食管鳞癌患者血清中自然杀伤细胞表面抑制性受体A(NKG2A)和自然杀伤细胞表面活化性受体D(NKG2D)表达水平的特点,探讨NKG2A和NKG2D在食管鳞癌不同病理分期的表达意义,并研究NK细胞、NKG2A、NKG2D与病理分期的相关性。方法用流式细胞仪分析92例食管鳞癌患者及50例健康志愿者外周血NK细胞数量及其NKG2A和NKG2D的表达情况。结果与正常对照组相比,食管鳞癌患者外周血NK细胞表达增加[(9.97±4.25)%vs.(16.22±8.91)%,t'=-5.646,P<0.01],NK细胞表面NKG2A的表达水平升高[(35.19±17.73)%vs.(47.35±18.88)%,t=-3.742,P<0.01],NKG2D的表达水平降低[(83.20±3.85)%vs.(80.60±9.09)%,t'=1.925,P=0.019];食管鳞癌患者NKG2A/NKG2D的比值与其病理分期呈正相关性(r=0.333,P<0.01),行线性回归分析得F=7.413,P=0.008,按α=0.05水准,回归方程为:Y(NKG2A/NKG2D的比值)=0.105X(食管鳞癌病理分期)+0.347;R2=0.276。结论食管鳞癌患者机体NK细胞数目增多,NKG2A/NKG2D比值与食管鳞癌病理分期进展呈正相关;降低NKG2A,提高NKG2D的表达水平,能增强NK细胞对肿瘤的杀伤活性,从而为食管鳞癌的免疫治疗开创新的思路。 Objective To analyse the expression levels of NKG2A and NKG2D in different pathological (TNM) stage of esophageal squamous cell carcinoma patients, discuss the meaning and research of correlation between NK cells,NKG2A, NKG2D and pathological stage. Methods Using flow cytometry to analyse the numbers of NK cells and expression of NKG2A and NKG2D in peripheral blood of 92 cases esophageal squamous cell carcinoma patients and 50 healthy volunteers. Results Compared with the normal control group, the expression level of NK cells in peripheral blood of esophageal squamous cell carcinoma patients increased [ (9. 97 ±4. 25 ) % vs. ( 16. 22 ± 8.91 ) %, t' = - 5. 646, P 〈 0. 01 ], and the expression level of its surface receptor NKG2A increased [ (35. 19 ± 17. 73)% vs. (47. 35 ± 18.88)% ,t = -3. 742,P 〈0. 01 ] ,but the expression level of NKG2D reduced [ (83. 20±3.85)% vs. (80. 60 ±9.09)% ,t' = 1. 925 ,P =0. 019]. It was showed a positive correlation between the ratio of NKG2A/NKG2D and the pathological stage of esophageal squamous cell carcinoma( r = 0. 333, P 〈 0. 01 ), Line linear regression analysis (F = 7. 413, P = 0. 008, at ot = 0. 05 level)got regression equation : Y (NKG2A/NKG2D ratio) = 0. 105X (pathological stage of esophageal squamous cell carcinoma) + 0.347 (R2 = 0.276 ). Conclusions The number of NK cells in esophageal squamous cell carcinoma increased. NKG2A/NKG2D ratio and the pathological stage progress of esophageal squamous cell carcinoma showed a positive correlation. Reduced NKG2A,increased NKG2D expression levels can enhance killing activity of NK cells, so as to open up new ideas about the esophageal squamous cell carcinoma immune therapy.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第8期67-70,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 食管肿瘤 肿瘤分期 杀伤细胞 天然 NKG2A NKG2D Esophageal neoplasms Neoplasm staging Killer cells,natural NKG2A NKG2D
  • 相关文献

参考文献13

  • 1蒋盼,汪华.自然杀伤细胞表面受体NKp46的研究进展[J].中华临床医师杂志(电子版),2011,5(22):6711-6714. 被引量:5
  • 2Moretta L,Bottino C,Pende D. Human natural killer cells:their origin,receptors and function[J].European Journal of Immunology,2002.1205-1211.
  • 3Kim R,Emi M,Tanabe K. Cancer immunoediting from immune surveillance to immune escape[J].Immunology,2007.1-14.doi:10.1111/j.1365-2567.2007.02587.x.
  • 4Garzetti GG,Cignitti M,Marchegiani F. Natural killer cell activity in patients with gynecologic malignancies:correlation with histologic grading and stage of disease[J].Gynecologic and Obstetric Investigation,1992.49-51.
  • 5沈亚娟,张建,田志刚.肿瘤患者自然杀伤细胞受体NKG2A和NKG2D的表达[J].检验医学,2008,23(4):384-387. 被引量:9
  • 6曾小辉,沙卫红,李瑜元,聂玉强,黎庆宁,梁培智.原发性肝癌患者外周血自然杀伤细胞受体NKG2D的表达及意义[J].中华医学杂志,2009,89(18):1272-1274. 被引量:7
  • 7Hui LC,Zacharie B. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line,YTINDY,leads to HLA class imediated inhibition of cytotoxicity in the p58.2-but not the CD94/NKG2A-expressing transfectant[J].Cellular Immmoligy,2002.57-70.
  • 8Groh V,Wu J,Yee C. Tumor-derived soluble MIC ligands impair expression of NKG2D and T cell activation[J].Nature,2002.734-738.
  • 9高峻,乔丽娟.NK细胞活化性受体NKG2D及其配体MICA在胃肠道肿瘤免疫逃逸机制中的作用[J].肿瘤研究与临床,2009,21(6):411-413. 被引量:1
  • 10Diefenbach A,Tomasello E,Lucas M. Selective associations with singaling proteins Determine stimulatory versus costimulatory activity of NKG2D[J].Nature Immunology,2002.1142-1149.

二级参考文献73

  • 1慢性乙型肝炎防治指南[J].中华传染病杂志,2005,23(6):421-431. 被引量:824
  • 2周智锋,叶韵斌,陈强.MICA蛋白在肿瘤生物治疗中的作用[J].中国肿瘤生物治疗杂志,2006,13(4):311-314. 被引量:3
  • 3Coudert JD, Held W. The role of the NKG2D receptor for tumor immunity. Semin Cancer Biol, 2006, 16:333-343.
  • 4Groh V ~ Wu J, Yee C, et al. Tumor-derived soluble MIC ligands impair eexpression of NKG2D and T cell activation. Nature, 2002, 419:734-738.
  • 5Wu JD, Higgins LM, Steinle A, et al. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest, 2004, 114:560-568.
  • 6Doubrovina ES, Doubrovin MM, Vider E, etal. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol, 2003, 171:6891-6899.
  • 7Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol, 2001, 22: 633-640.
  • 8Groh V, Wu J, Yee C, et al. Tumour-drived soluble MIC lignands impair expair expression of NKG2D and T-cell activation. Nature, 2002, 419:734-738.
  • 9Raffaghello L Prigione I, Airoldi I, et al. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia, 2004, 6: 558-568.
  • 10Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases. Int J Cancer, 2006, 118: 684-687.

共引文献21

同被引文献15

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部